Table 2.
Effects of urethane–xylazine anesthesia after a 20-min baseline (0 min) period
Time (min) |
||||||||||||||||
0 | 1–20 | 21–40 | 41–60 | 61–80 | 81–100 | 101–120 | 121–140 | 141–160 | 161–180 | 181–200 | 201–220 | 221–240 | 241–260 | 261–280 | 281–300 | |
P1 latency | ||||||||||||||||
O2 | 1253 ± 91 | 1249 ± 86 | 1245 ± 89 | 1244 ± 90 | 1240 ± 90 | 1245 ± 85 | 1243 ± 78 | 1242 ± 78 | 1248 ± 78 | 1247 ± 79 | 1247 ± 81 | 1245 ± 81 | 1249 ± 87 | 1262 ± 95a | 1261 ± 92a | 1258 ± 89a |
No O2 | 1274 ± 34 | 1287 ± 38 | 1283 ± 41 | 1277 ± 37 | 1275 ± 38 | 1275 ± 38 | 1279 ± 48 | 1275 ± 41 | 1288 ± 35 | 1300 ± 42 | 1299 ± 25 | 1293 ± 22 | 1297 ± 26 | 1280 ± 30b | 1278 ± 36b | 1275 ± 35b |
N1 latency | ||||||||||||||||
O2 | 1551± 101 | 1540 ± 97 | 1532 ± 95 | 1524 ± 100 | 1523 ± 99 | 1525 ± 93 | 1524 ± 93 | 1526 ± 82 | 1529 ± 83 | 1527 ± 80 | 1523 ± 84 | 1531 ± 81 | 1529 ± 84 | 1533 ± 90a | 1538 ± 94a | 1537 ± 98a |
No O2 | 1553 ± 47 | 1552 ± 45 | 1545 ± 40 | 1544 ± 37 | 1542 ± 40 | 1549 ± 49 | 1555 ± 64 | 1549 ± 35 | 1564 ± 39 | 1570 ± 36 | 1562 ± 25 | 1568 ± 32 | 1563 ± 27 | 1569 ± 33b | 1570 ± 39b | 1563 ± 33b |
P2 latency | ||||||||||||||||
O2 | 1932 ± 92 | 1915 ± 87 | 1918 ± 86 | 1906 ± 85 | 1903 ± 92 | 1898 ± 92 | 1893 ± 97 | 1900 ± 84 | 1901 ± 80 | 1903 ± 82 | 1896 ± 84 | 1886 ± 82 | 1889 ± 89 | 1907 ± 84a | 1905 ± 96a | 1904 ± 94a |
No O2 | 1935 ± 41 | 1930 ± 36 | 1925 ± 26 | 1925 ± 43 | 1921 ± 41 | 1925 ± 49 | 1920 ± 41 | 1918 ± 36 | 1919 ± 29 | 1921 ± 29 | 1913 ± 29 | 1915 ± 24 | 1911 ± 28 | 1913 ± 35b | 1906 ± 35b | 1893 ± 9b |
P1–N1 amplitude | ||||||||||||||||
O2 | 1.10 ±0.27 | 1.11 ±0.26 | 1.14 ± 0.28 | 1.14 ± 0.27 | 1.15 ±0.24 | 1.17 ± 0.30 | 1.13 ± 0.28 | 1.15 ± 0.28 | 1.18 ± 0.26 | 1.14 ± 0.32 | 1.19 ± 0.29 | 1.17 ± 0.30 | 1.14 ± 0.30 | 1.00 ± 0.07a | 1.06 ± 0.10a | 1.07 ± 0.10a |
No O2 | 0.97 ±0.30 | 0.97 ±0.25 | 0.96 ± 0.30 | 0.94 ± 0.34 | 0.95 ±0.34 | 0.95 ± 0.38 | 0.95 ± 0.36 | 0.95 ± 0.34 | 0.96 ± 0.30 | 0.89 ± 0.31 | 0.88 ± 0.32 | 0.91 ± 0.32 | 0.95 ± 0.38 | 0.79 ± 0.18b | 0.85 ± 0.26b | 0.84 ± 0.25b |
P2–N1 amplitude | ||||||||||||||||
O2 | 0.94 ±0.40 | 0.97 ±0.42 | 1.06 ± 0.35 | 1.00 ± 0.36 | 1.01 ±0.33 | 0.99 ± 0.31 | 1.02 ± 0.38 | 1.02 ± 0.38 | 0.97 ± 0.37 | 0.94 ± 0.33 | 0.90 ± 0.30 | 0.85 ± 0.32 | 0.85 ± 0.26 | 0.82 ± 0.20a | 0.83 ± 0.18a | 0.84 ± 0.18a |
No O2 | 0.91 ±0.42 | 0.93 ±0.43 | 0.91 ± 0.40 | 0.92 ± 0.36 | 0.89 ±0.39 | 0.85 ± 0.47 | 0.83 ± 0.46 | 0.85 ± 0.41 | 0.82 ± 0.37 | 0.75 ± 0.35 | 0.72 ± 0.31 | 0.71 ± 0.31 | 0.71 ± 0.30 | 0.61 ± 0.24b | 0.60 ± 0.29b | 0.65 ± 0.34b |
Threshold | ||||||||||||||||
O2 | −10.5 ± 0.0 | −11.0 ± 1.2 | −10.5 ± 0.0 | −10.5 ± 0.0 | −10.5 ± 1.9 | −10.0 ± 1.2 | −10.0 ± 1.2 | −10.5 ± 1.9 | −9.5 ± 1.6 | −10.5 ± 0.0 | −10.0 ± 1.2 | −11.5 ± 1.6 | −10.0 ± 1.2 | −9.9 ± 1.3a | −10.5 ± 0.0a | −10.5 ± 0.0a |
No O2 | −9.5 ± 1.6 | −11.0 ± 2.3 | −10.5 ± 0.0 | −9.5 ± 1.6 | −11.0 ± 2.3 | −10.5 ± 2.7 | −8.5 ± 1.6 | −8.5 ± 1.6 | −10.0 ± 1.2 | −9.5 ± 1.6 | −10.0 ± 2.3 | −10.0 ± 1.2 | −10.0 ± 1.2 | −12.0 ± 1.7b | −12.0 ± 1.7b | −11.3 ± 1.5b |
VsEP latencies (µs) and amplitudes (µV) obtained at +6dB and 1.0 g/ms and response thresholds over time are shown. Results from O2-supplemented and nonsupplemented groups under urethane–xylazine anesthesia are represented. Each time period was characterized by averaging 4 or 5 consecutive measurements at approximately 5-min intervals. Brain temperature was controlled at 36.0 ± 0.2 °C, and rectal temperatures were maintained at 37.0 ± 0.2 °C in all animals. Data are shown as mean ± 1 SD of 6 animals, except where noted. Sample size decreased after 240 minutes because some animals were euthanized.
n = 5.
n = 4.